BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

Applied Nanolayers and SoundCell awarded grant to develop groundbreaking graphene based antibiotic sensitivity test

Applied Nanolayers BV (ANL) and SoundCell BV (a spin-off from Technische Universiteit Delft TUD), today announced they have received 275,000...

March 10, 2023 | News

Alnylam and Medison Pharma expand RNAi Therapeutics Partnership

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma co...

March 09, 2023 | News

Study finds plate choice can affect EM microbial air sampling accuracy and Annex 1 compliance

Cherwell, specialists in cleanroom microbiology solutions for the pharmaceutical, healthcare and related industries, has published the findings of an...

March 07, 2023 | News

Sanyou Biopharmaceuticals expanding its business outreach to a central hub of biotech network

Sanyou Biopharmaceuticals, a leading provider of biotech CRDMO services, is opening a new office in Cambridge Innovation Centre, CIC, marking a new era tow...

March 02, 2023 | News

ClinChoice Acquires CROMSOURCE, Expanding its Global Presence

Founded in 1997, CROMSOURCE has a proven track record of supporting global pharmaceutical, biotechnology, and medical device clients with exceptional clini...

March 02, 2023 | News

BRIM appoints Andrew Lin as Chairman and Dr. Wen Chyi Shyu as CEO, secures $18M in Series E funding, and advances clinical trials for Dry Eye Disease and Neurotrophic Keratitis treatments

What led to the decision to elect Andrew Lin as the new Chairman of the Board, and how do you believe he will contribute to BRIM's continued succ...

March 01, 2023 | Opinion

Gene Solutions' Latest Update: Promising Multi-Cancer Early Detection in Southeast Asia

Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...

March 01, 2023 | News

Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA

FP002 is a humanized anti-CD47 IgG4 monoclonal antibody, developed and patented by Fapon Biopharma. It binds strongly to the CD47 protein on the surface of...

February 23, 2023 | News

BRIM Biotechnology announces new leadership team

BRIM Biotechnology, Inc. (BRIM, TPEx 6885), a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and...

February 21, 2023 | News

Celltrion and LISCure Biosciences to develop novel microbiome treatment for Parkinson's disease

Co-research and co-development of novel microbiome therapeutics Discovery of new candidates to meet high unmet medical needs in Parkinson's disease U...

February 21, 2023 | News

RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore

The clinical trial aims to evaluate three of RVAC's COVID-19 vaccine candidates that include one against the ancestral strain, one against an Omicron strai...

February 21, 2023 | News

"Fueling Growth and Innovation: The Rise of Biotech Investment in the Asia Pacific Region"

According to a report by Deloitte, the APAC biotech market is expected to grow at a compound annual growth rate (CAGR) of 10.9% between 2020 and 2025, with...

February 20, 2023 | News

Global Sarcoma Therapy Now Approved for New Zealand Patients

Globally regarded soft-tissue sarcoma therapy has been approved by Medsafe for New Zealand patients YONDELIS® (trabectedin) demonstra...

February 18, 2023 | News

Oxford Nanopore Technologies teams up with UPS Healthcare to accelerate delivery of next-generation DNA sequencing technology

Oxford Nanopore Technologies today announced an extension of its collaboration with UPS Healthcare to accelerate the delivery of Oxford Nanopore DNA/RNA se...

February 16, 2023 | News

Stay Connected